Atención prenatal desde casa
Pulsenmore (NASDAQ and TASE: PLSM) es líder mundial en tecnología de ultrasonidos para el hogar conectado.
Nuestras innovadoras soluciones hacen que la ecografía sea intuitiva, accesible y centrada en el paciente, ampliando el acceso, mejorando la calidad de la atención y reduciendo la carga de los sistemas de salud.
¿Qué representamos?
Atención prenatal remota y confiable
Pulsenmore es una plataforma digital de atención prenatal que permite realizar ecografías y recibir atención desde casa. Recetada por un médico, nuestra solución mejora el acceso a la atención, mejora la gestión de recursos y proporciona mayor flexibilidad a los cuidadores.
Colaboraciones y reconocimientos
Atención prenatal de próxima Generación
El dispositivo de ultrasonido Pulsenmore se conecta perfectamente al teléfono inteligente personal del paciente.
Una aplicación móvil fácil de usar guía a la futura madre.
Cada exploración es diagnosticada por un médico y puede documentarse en el EMR del paciente.
El dispositivo se puede utilizar en tiempo real con un médico o de forma asincrónica.
Solución práctica y segura para la evaluación ecográfica remota del bienestar fetal.
Prescrito por un médico para un cuidado prenatal continuo desde el hogar.
Empoderamos a las futuras mamás durante todo su embarazo.
¿Desea ver en acción la atención centrada en la paciente?
Solicitar una demostración
Vea el modo guiado por el médico
Vea el modo guiado por app
Impacto de la tecnología
Cargando…
Exploraciones domiciliarias realizadas hasta la fecha
86.3%
Las usuarias encuestadas informan de una mejor experiencia durante el embarazo
63%
Visitas clínicas más cortas
90%
Las usuarias encuestadas informan de una reducción de la ansiedad y el estrés relacionados con el embarazo
La solución Pulsenmore permite un mejor acceso y continuidad de la atención con una detección más temprana de señales de advertencia, alertando sobre condiciones de riesgo que requieren intervención.
Ver una historia de la vida real
Centro de recursos
The publications and abstracts featured in the Resource Center include research from around the world and may reference indications that are not approved in all countries.
Recursos clínicos
Comunicado de prensa
Webinars
Recursos clínicos
This systematic review examined the potential role of tele-ultrasound, handheld, and self-operated ultrasound devices in prenatal care. It assessed how this technology could have enhanced accessibility, accuracy, and convenience for pregnant individuals, especially in remote or underserved areas. The review highlighted Pulsenmore technology as the leading and sole innovation for patient-operated home ultrasound and underscored …
➜
The home ultrasound device was feasible, comparable, and well-correlated with standard IC scans, laying the basis for remote home-based monitoring of follicular development during ovarian stimulation. We believe this also applies to monitoring milder stimulations and even natural cycles.
➜
In this large-scale, retrospective real-world study, we aimed to examine the association between home ultrasound service utilization during pregnancy and adverse pregnancy outcomes.
➜
Remote visits had a success rate of 97.4% (38 of 39), with significantly shorter durations compared with in-clinic visits (median 59.0 min vs. 159.0 min, P
➜
With appropriate patient selection, some older, chronically ill patients can generate high-quality LUS self-images that are non-inferior to those generated by trained physicians using the same device, thereby enabling remote detection of interstitial changes, which may indicate pulmonary congestion. The accuracy of the home ultrasound device was comparable to that of the GS device for …
➜
Pulsenmore ES is a self-scanning ultrasound system for remote fetal assessment. It is composed of a hand-held transducer that serves as a smartphone cradle coupled with an application and clinician’s web-viewer dashboard. Recently, a novel capability was added to the system allowing for offline fetal heart rate (FHR) and maximal vertical pocket (MVP) measurements. The …
➜
Integrating routine home-ultrasound telemedicine visits into prenatal care can significantly reduce maternal anxiety during pregnancy and contribute to greater maternal attachment in individuals with a history of recurrent pregnancy loss. These results emphasize the potential benefits of home ultrasound as a tool to alleviate anxiety, provide a sense of control, and foster a deeper maternal …
➜
A systematic search provided 31 studies. The risk of bias for each study was assessed. Results were analyzed and presented in a narrative overview in four domains: tele‐ultrasound, patient‐operated ultrasound, handheld devices and low‐ and middle‐income countries .
➜
Remote fetal well-being assessment is feasible and time-saving and results in high patient satisfaction. This novel paradigm of comprehensive remote maternal and fetal assessment is associated with important clinical, socioeconomic, and logistics advantages.
➜
Abstract: In light of the COVID-19 pandemic and other emergencies, telehealth has become vital for improving women’s health since it offers easy accessto medical care. This strategy makes virtual consultations, […]
➜
Adoption of telehealth technologies may improve the antenatal care experience for women and reducehealthcare expenditure without adversely impacting health outcomes for the mother or baby. More studies are war-ranted to confirm telehealth does not alter the risk of rare outcomes such as maternal or neonatal mortality.
➜
Self-examination using mobile systems for fetal ultrasound during pregnancy was generally acceptable for the pregnant women who participated. The analysis showed that the image quality was adequate for assessing amniotic fluid in most participants. Identification of fetal heartbeat and fetal facial profile was more challenging for the women. Further studies are needed to determine whether …
➜
The Pulsenmore ultrasound system is a feasible solution for remote sonographic fetal assessment. Further studies are needed to assess its role and impact in telehealth antenatal care and fetal surveillance.
➜
A look at how the COVID-19 pandemic has reshaped the prenatal treatment model for the benefit of patients and clinicians Colleen C. Denny, MD, and Steven R. Goldstein, MD, NCMP, CCD
➜
Comunicado de prensa
Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation Commercial agreement potentially valued at approximately $4.5 million over five years following 18 month […]
➜
➜
RAMAT GAN, Israel, Nov. 3, 2025 /PRNewswire/ — Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorization for the Pulsenmore ES, a home-use prenatal ultrasound platform that enables expectant mothers to perform guided scans at home interpreted by remote physicians.
➜
Pulsenmore (TASE: PULS), a pioneering provider of home-based ultrasound technology, has announced the renewal and expansion of its strategic partnership with Clalit Health Services, Israel's largest HMO. Over the next five years, Pulsenmore will supply 25,000 units of its advanced home ultrasound devices to support Clalit's commitment to accessible, high-quality prenatal care.
➜
Pulsenmore secured a commercial agreement with Sheba Medical Center, Tel Hashomer for remote patient monitoring of highrisk pregnancies using its’ home ultrasound solution. Sheba Medical Center, will utilize Pulsenmore's solution as part of its’ obstetrics department in the 'Sheba Beyond virtual hospital, offering top-quality medical services to insured individuals across various health funds. Full article …
➜
Pulsenmore (TASE:PULS), the world leader in self-scan ultrasound technology for at-home use and remote clinical diagnosis, announces its new clinical study collaboration with Michigan Medicine. The study will examine the ability to conduct a remote biophysical profile (BPP) test, by using the Pulsenmore home ultrasound with the guidance of a remote clinician, potentially reducing the clinical …
➜
Pulsenmore's CEO, Dr. Elazar Sonnenschein, has been named "Man of the Year" by Yedioth Ahronoth, the most renowned daily publication in Israel. The feature highlighted his achievements, showcasing his leadership and our collective efforts to make Pulsenmore a healthcare trailblazer.
➜
RAMAT GAN, Israel, Jan. 10, 2024 /PRNewswire/ — Pulsenmore (TASE: PULS), the global leader in self-scan ultrasound technology for home use, proudly announces the approval of its pioneering prenatal care solution by the Brazilian Health Regulatory Agency (ANVISA), marking a significant milestone in the company's international expansion.
➜
RAMAT GAN, Israel, Jan. 10, 2024 /PRNewswire/ — Pulsenmore (TASE: PULS), the global leader in self-scan ultrasound technology for home use, proudly announces the approval of its pioneering prenatal care solution by the Brazilian Health […]
➜
A new handheld, self-scanning ultrasound device that attaches to a smartphone allows pregnant women to see their baby in the womb at any time and in the comfort of their own home, without a visit to a hospital or clinic.
➜
Discover Israel's thriving innovation ecosystem and the latest technologies on the horizon in this special edition as is takes a deep dive into Israel's remarkable 75-year history of innovation, highlighting the country's key contributions to science and technology. One of the featured technologies is Pulsenmore, a remote ultrasound device that's revolutionizing at-home maternal fetal monitoring.
➜
Apr. 7, 2022, 08:00 AM RAMAT GAN, Israel, April 7, 2022 /PRNewswire/ — Home ultrasound developer Pulsenmore Ltd. (TASE: PULS) today announced the appointment of Hagar Spits as General Manager North America, as the company establishes U.S. operations […]
➜
Discover Israel's thriving innovation ecosystem and the latest technologies on the horizon in this special edition as is takes a deep dive into Israel's remarkable 75-year history of innovation, highlighting the country's key contributions to science and technology. One of the featured technologies is Pulsenmore, a remote ultrasound device that's revolutionizing at-home maternal fetal monitoring.
➜
Pulsenmore has announced partnership with GE Healthcare, including an agreement to invest up to $50 million in Pulsenmore and distribution of its’ products in key markets. This investment is aimed […]
➜
“In an office near Tel Aviv, a doctor checks the lungs of a Ukrainian refugee who is 2,000 kilometers away. It’s part of a new “virtual hospital” that has Israeli medical staff caring for people injured or displaced in Russia’s onslaught…. One of the systems in use, Pulsenmore, is a portable prenatal ultrasound device that …
➜
"This is the first time I know of that a humanitarian mission is adding extraordinary value to the first responders there,” says Dr. Galia Barkai, director general of Sheba Beyond…. using Pulsenmore’s prenatal ultrasound device that takes images at the point of care to be analyzed by Sheba OB/GYNs in Israel.
➜
Israeli home ultrasound developer Pulsenmore announced on Monday it has secured a multimillion-dollar contract to supply its portable device for self-examination of follicles in IVF (in vitro fertilization) and fertility preservation processes to Clalit Health Services, Israel’s largest healthcare organization.
➜
First purchase order for Pulsenmore's home ultrasound device for IVF processes
➜
Medika Life has featured Pulsenmore in first place in its watchlist for digital health companies impacting the healthcare industry in 2021. “This is a truly revolutionary device, enabling pregnant women to monitor fetal growth and development remotely.”
➜
Previous
Next
Webinars
Our recent webinar brought together leading experts in maternal-fetal health to explore the complex psychobiological effects of prenatal anxiety on both mother and child…
➜
We're absolutely thrilled by the vibrant energy following our recent webinar, a collaborative effort between Women's Health Innovation Series , Sheba Medical Center, Tel Hashomer, and Beilinson – Rabin Medical Center.
➜
Dr. Alex Peahl (University of Michigan) and Dr. Avi (Abraham) Tsur, MD (Sheba Medical Center, Tel Hashomer) discuss the shift towards more flexible, personalized, and hybrid hashtag#prenatalcare.
➜
Previous
Next
Testimonios